Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-15

FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GENVOYA (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) from Gilead Sciences. The approval upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genvoya (elvitegravir; cobicistat; emtricitabine; tenofovir alafenamide)

Snippet

SUPPL AP for GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)